Investigating the Role of 13cis Retinoic Acid in the Treatment of COVID-19 and Enhancement of Its Spike Protein Based Vaccine Efficacy and Safety.

PHASE1,PHASE2

Phase

UNKNOWN

Status

360

Enrollment

OTHER

Sponsor class

Conditions

DRUG: Oral 13 cis retinoic acid
DRUG: Aerosolized 13 cis retinoic acid
COMBINATION_PRODUCT: 13 cis retinoic acid doses orally in combination with spike protein based vaccine
COMBINATION_PRODUCT: Aerosolized 13 cis retinoic acid in combination with spike protein based vaccine
BIOLOGICAL: Biological: spike protein based vaccine such as ChAdOx1 nCoV-19 vaccine

Kafrelsheikh University